Dengue fever, caused by a flavivirus named DENV, is a major global health challenge, risking almost half of the world's ...

Takeda plans to launch its dengue vaccine, Qdenga, in India by next year, partnering with Biological E to support the 'Make-in-India' initiative. The company will employ a tiered pricing model to ...

India’s first indigenous dengue vaccine, DengiAll, is currently in Phase 3 trials involving over 10,335 participants across ...

S’gor exco member talks costs and community hygiene as 2024 dengue cases rise past 30,000 SELANGOR has no plans to change its strategy of emphasising prevention measures to combat dengue, even ...